Oesophagus

A cohort study involving more than 1500 patients suggests that risk of significant bleeding and mortality following PEG placement was...

A phase 3 trial reports that pembrolizumab plus chemotherapy as compared to placebo plus chemotherapy resulted in a meaningful improvement...

Results of an European prospective registry involving more than 22.000 patients indicate that eradication therapies frequently induce adverse events which...

In a proof-of-concept study, therapy with ZED1227, an oral inhibitor of transglutaminase 2, attenuated gluten-induced duodenal mucosal damage in patients...

In a proof-of-concept study, immune modulating gliadin nanoparticles (TAK-101) were well tolerated and prevented gluten-induced immune activation in patients with...

Nivolumab plus chemotherapy resulted in superior overall survival as well as progression-free survival as compared to chemotherapy alone in a...

Results of prospective studies involving more than 200,000 participants reveal that regular use of PPIs was associated with a higher...

This meta-analysis involving more than 170, 000 patients revealed that among adults with obesity, metabolic-bariatric surgery was associated with substantially...

Radiofrequency ablation modestly reduced the prevalence of low-grade dysplasia as well as malignant progression risk at 3 years in a...

Results of 3 independent patient cohorts show that IgA transglutaminase titers of ≥ 10 x ULN have a strong predictive...